These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 17763407
1. The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register. Bukhari M, Thomson W, Naseem H, Bunn D, Silman A, Symmons D, Barton A. Arthritis Rheum; 2007 Sep; 56(9):2929-35. PubMed ID: 17763407 [Abstract] [Full Text] [Related]
2. Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies. Farragher TM, Lunt M, Plant D, Bunn DK, Barton A, Symmons DP. Arthritis Care Res (Hoboken); 2010 May; 62(5):664-75. PubMed ID: 20461787 [Abstract] [Full Text] [Related]
3. Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis. Burr ML, Viatte S, Bukhari M, Plant D, Symmons DP, Thomson W, Barton A. Arthritis Res Ther; 2012 May 09; 14(3):R109. PubMed ID: 22571727 [Abstract] [Full Text] [Related]
4. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis]. Xie QB, Yin G. Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May 09; 40(3):508-12. PubMed ID: 19627016 [Abstract] [Full Text] [Related]
5. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA. Agrawal S, Misra R, Aggarwal A. Clin Rheumatol; 2007 Feb 09; 26(2):201-4. PubMed ID: 16572283 [Abstract] [Full Text] [Related]
6. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis. Chang PY, Yang CT, Cheng CH, Yu KH. Int J Rheum Dis; 2016 Sep 09; 19(9):880-6. PubMed ID: 25940989 [Abstract] [Full Text] [Related]
7. The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus. Popescu C, Zofotă S, Bojincă V, Ionescu R. Rom J Intern Med; 2013 Sep 09; 51(3-4):179-87. PubMed ID: 24620631 [Abstract] [Full Text] [Related]
8. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, Rantapää-Dahlqvist S. Ann Rheum Dis; 2006 Apr 09; 65(4):453-8. PubMed ID: 16176994 [Abstract] [Full Text] [Related]
9. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis. Nielen MM, van der Horst AR, van Schaardenburg D, van der Horst-Bruinsma IE, van de Stadt RJ, Aarden L, Dijkmans BA, Hamann D. Ann Rheum Dis; 2005 Aug 09; 64(8):1199-204. PubMed ID: 15640269 [Abstract] [Full Text] [Related]
10. The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis. Mjaavatten MD, van der Heijde D, Uhlig T, Haugen AJ, Nygaard H, Sidenvall G, Helgetveit K, Kvien TK. Arthritis Res Ther; 2010 Aug 09; 12(3):R76. PubMed ID: 20444271 [Abstract] [Full Text] [Related]
11. Evaluation of third generation anti-CCP antibodies in the diagnosis of rheumatoid arthritis from undifferentiated polyarthritis after 4 years of follow-up. Caro-Oleas JL, Fernández-Suárez A, Reneses Cesteros S, Porrino C, Núñez-Roldán A, Wichmann Schlipf I. Clin Exp Rheumatol; 2008 Aug 09; 26(3):461-3. PubMed ID: 18578970 [Abstract] [Full Text] [Related]
12. Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients. Spârchez M, Miu N, Bolba C, Iancu M, Spârchez Z, Rednic S. Clin Rheumatol; 2016 Mar 09; 35(3):601-7. PubMed ID: 25994613 [Abstract] [Full Text] [Related]
14. Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis. Boire G, Cossette P, de Brum-Fernandes AJ, Liang P, Niyonsenga T, Zhou ZJ, Carrier N, Daniel C, Ménard HA. Arthritis Res Ther; 2005 Mar 09; 7(3):R592-603. PubMed ID: 15899046 [Abstract] [Full Text] [Related]
16. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA. J Rheumatol; 2002 Oct 09; 29(10):2074-6. PubMed ID: 12375314 [Abstract] [Full Text] [Related]
17. Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis. Inanc N, Dalkilic E, Kamali S, Kasapoglu-Günal E, Elbir Y, Direskeneli H, Inanc M. Clin Rheumatol; 2007 Jan 09; 26(1):17-23. PubMed ID: 16538391 [Abstract] [Full Text] [Related]
18. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S. J Rheumatol; 2006 Dec 09; 33(12):2390-7. PubMed ID: 16924694 [Abstract] [Full Text] [Related]
19. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness. del Val del Amo N, Ibanez Bosch R, Fito Manteca C, Gutierrez Polo R, Loza Cortina E. Clin Exp Rheumatol; 2006 Dec 09; 24(3):281-6. PubMed ID: 16870095 [Abstract] [Full Text] [Related]
20. Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis. Mewar D, Coote A, Moore DJ, Marinou I, Keyworth J, Dickson MC, Montgomery DS, Binks MH, Wilson AG. Arthritis Res Ther; 2006 Dec 09; 8(4):R128. PubMed ID: 16859535 [Abstract] [Full Text] [Related] Page: [Next] [New Search]